Journal: Evidence-based Complementary and Alternative Medicine : eCAM
Article Title: Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats
doi: 10.1155/2016/1359105
Figure Lengend Snippet: Changes in MPO (a1, b1), PMN elastase (a2, b2), IL-1 β (a3, b3), TNF- α (a4, b4), IL-6 (a5, b5), and IL-10 (a6, b6) levels in the serum (a) and BALF (b) from sequentially/nonsequentially treated COPD rats. AE: acute exacerbation; BYG: Bufei Yishen Granule; COPD: chronic obstructive pulmonary disease; IL: interleukin; MPO: myeloperoxidase; MXF: moxifloxacin; NS: normal saline; PMN: polymorphonuclear; RW: risk window; TNF: tumor necrosis factor; TSG: Tongsai Granule; STL: salbutamol. N = 6. ∗ P < 0.05, versus Control group; # P < 0.05, versus COPD group; ▲ P < 0.05, versus AECOPD group; ■ P < 0.05, versus TSG/NS group; □ P < 0.05, versus MXF+STL/NS group; ● P < 0.05, versus TSG/BYG group; ○ P < 0.05, versus MXF+STL/STL group.
Article Snippet: The left BALF was centrifuged, and the supernatant was collected to determine IL-1 β , TNF- α , IL-6, IL-10, MPO, and PMN elastase levels by ELISA (Boster, Wuhan, China).
Techniques: Saline, Control